Please use this identifier to cite or link to this item:
Type: Artigo
Title: Skin and oral lesions associated to imatinib mesylate therapy
Author: Basso, Fernanda Gonçalves
Boer, Camila Cominato
Corrêa, Maria Elvira Pizzigatti
Torrezan, Marcia
Cintra, Maria Letícia
Magalhães, Marina H. C. Gallottini de
Santos, Paulo da Silva
Souza, Cármino Antônio de
Abstract: Imatinib mesylate is a tyrosine kinase inhibitor used to treat chronic myeloid leukemia (CML) throughout all the phases of the disease. In most cases, this drug is well tolerated; however, some cases experience side effects. Skin rashes and oral lesions are uncommon and appear to be dose-dependent. The authors report two cases of CML Ph+ in chronic phase patients who presented skin and oral lesions probably induced by imatinib therapy
Subject: Imatinibe
Efeitos colaterais
Country: Alemanha
Editor: Springer
Rights: Fechado
Identifier DOI: 10.1007/s00520-008-0536-8
Date Issue: 2009
Appears in Collections:FCM - Artigos e Outros Documentos
HEMO - Artigos e Outros Documentos

Files in This Item:
File Description SizeFormat 
000264183100018.pdf301.66 kBAdobe PDFView/Open

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.